HIPREX

This brand name is authorized in United States. It is also authorized in Australia, Ecuador, Estonia, Finland, Mexico, New Zealand, UK.

Active ingredients

The drug HIPREX contains one active pharmaceutical ingredient (API):

1	Methenamine UNII M329791L57 - METHENAMINE HIPPURATE
	Methenamine is a urinary antibacterial agent with a wide antibacterial spectrum covering both gram-positive and gram-negative organisms. Urinary antibacterial activity can be shown within 30 minutes of administration.
	Read more about Methenamine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
HIPREX Tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01XX05	Methenamine	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XX Other antibacterials
Discover more medicines within J01XX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	3124K
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	1076-MEE-0615
EE	Ravimiamet	1879599
FI	Lääkealan turvallisuus- ja kehittämiskeskus	005769, 124339
GB	Medicines & Healthcare Products Regulatory Agency	36920, 398581
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	61866
NZ	Medicines and Medical Devices Safety Authority	1248
US	FDA, National Drug Code	30698-277